The Fort Worth Press - Inspire Veterinary Partners Announces up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

USD -
AED 3.6725
AFN 64.494756
ALL 81.598713
AMD 359.67278
ANG 1.789785
AOA 918.000208
ARS 1538.260398
AUD 1.421858
AWG 1.8025
AZN 1.693911
BAM 1.758181
BBD 2.017808
BDT 124.280834
BGN 1.747831
BHD 0.378105
BIF 3005.600554
BMD 1
BND 1.283543
BOB 11.917476
BRL 5.352201
BSD 1.001892
BTN 95.226537
BWP 13.859348
BYN 2.947424
BYR 19600
BZD 2.014932
CAD 1.406275
CDF 2314.999721
CHF 0.830245
CLF 0.024972
CLP 986.040307
CNY 6.66835
CNH 6.666145
COP 3151.86
CRC 455.595609
CUC 1
CUP 24.044517
CVE 99.123517
CZK 21.881896
DJF 178.40785
DKK 6.722025
DOP 61.444278
DZD 135.369852
EGP 56.14368
ERN 15
ETB 162.972609
EUR 0.899349
FJD 2.243699
FKP 0.75114
GBP 0.75245
GEL 2.570497
GGP 0.75114
GHS 11.676555
GIP 0.75114
GMD 73.999918
GNF 8866.375106
GTQ 7.656419
GYD 209.942467
HKD 7.84472
HNL 26.89794
HRK 6.76901
HTG 131.239943
HUF 330.105013
IDR 18166
ILS 3.098303
IMP 0.75114
INR 95.22695
IQD 1518.788206
IRR 1857000.000207
ISK 122.670033
JEP 0.75114
JMD 159.404525
JOD 0.709014
JPY 157.858024
KES 129.909972
KGS 87.449204
KHR 4090.273689
KMF 441.000077
KPW 899.999961
KRW 1337.48013
KWD 0.31132
KYD 0.834862
KZT 457.910823
LAK 22548.645041
LBP 89716.422674
LKR 333.065143
LRD 170.315667
LSL 16.709083
LTL 2.952739
LVL 0.60489
LYD 6.436563
MAD 9.868303
MDL 18.093068
MGA 4560.450921
MKD 55.35329
MMK 2099.630718
MNT 3601.077836
MOP 8.095253
MRU 40.249373
MUR 47.549701
MVR 15.449945
MWK 1737.250425
MXN 18.681115
MYR 4.079905
MZN 63.910092
NAD 16.709008
NGN 1344.540146
NIO 36.866069
NOK 9.334902
NPR 152.363829
NZD 1.783502
OMR 0.384498
PAB 1.001888
PEN 3.451546
PGK 4.491231
PHP 64.053502
PKR 277.234306
PLN 3.95895
PYG 5828.864747
QAR 3.652104
RON 4.811894
RSD 105.694014
RUB 80.501108
RWF 1482.753351
SAR 3.750764
SBD 8.064647
SCR 13.986932
SDG 601.515787
SEK 9.95784
SGD 1.28196
SHP 0.749344
SLE 22.874977
SLL 20969.504398
SOS 572.550994
SRD 37.6505
STD 20697.981008
STN 22.02465
SVC 8.766631
SYP 13001.999685
SZL 16.701501
THB 33.8175
TJS 9.217057
TMT 3.5
TND 3.000388
TOP 2.40776
TRY 49.837115
TTD 6.800611
TWD 32.414703
TZS 2644.982953
UAH 45.735578
UGX 4393.203883
UYU 40.165228
UZS 11956.976101
VES 886.72915
VND 25842
VUV 118.98361
WST 2.767767
XAF 589.934591
XAG 0.018563
XAU 0.000248143884
XCD 2.70255
XCG 1.805556
XDR 0.707052
XOF 589.934591
XPF 107.209637
YER 236.149824
ZAR 16.663225
ZMK 9001.205413
ZMW 20.204154
ZWL 321.999592
SSP 5745.470209
MXV 2.10654
  • RIO

    -0.3300

    97.04

    -0.34%

  • CMSC

    -0.0400

    20.67

    -0.19%

  • RELX

    0.0000

    33.41

    0%

  • RBGPF

    0.0000

    67.95

    0%

  • BCE

    -0.0700

    21.99

    -0.32%

  • BCC

    -0.0300

    75.66

    -0.04%

  • GSK

    0.8600

    51.08

    +1.68%

  • JRI

    -0.0300

    11.52

    -0.26%

  • NGG

    -0.1200

    76.68

    -0.16%

  • CMSD

    0.0900

    20.54

    +0.44%

  • BTI

    -0.0800

    55.75

    -0.14%

  • AZN

    2.0200

    168.1

    +1.2%

  • BP

    -1.4200

    43.16

    -3.29%

  • RYCEF

    0.4600

    19.7

    +2.34%

  • VOD

    0.0700

    17.02

    +0.41%

Inspire Veterinary Partners Announces up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Inspire Veterinary Partners Announces up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Inspire Veterinary Partners Announces up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

VIRGINIA BEACH, VA / ACCESS Newswire / March 25, 2025 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S.,today announced it has entered into a securities purchase agreement with an investor to purchase 1,092,896 shares of its common stock (or a pre-funded warrant in lieu thereof), Series A warrants to purchase 1,092,896 shares of common stock and Series B warrants to purchase 1,092,896 shares of common stock, pursuant to a registered direct offering for aggregate gross proceeds of approximately $2.0 million before deducting fees and other estimated offering expenses (the "Offering").The Series A warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares underlying the warrants (the "Stockholder Approval Date") and will expire five years from the Stockholder Approval Date. The Series B warrants will be exercisable beginning on the Stockholder Approval Date and will expire 18 months from the Stockholder Approval Date. The purchase price for one share of common stock (or pre-funded warrants in lieu thereof) and accompanying two warrants is $1.83. Approximately $2.0 million will be funded in full upon the closing of the Offering, and up to an additional $4.0 million may be funded upon full cash exercise of the warrants. No assurance can be given that any of the warrants will be exercised. The offering is expected to close on or about March 26, 2025, subject to the satisfaction of customary closing conditions.

Text size:

D. Boral Capital is acting as exclusive placement agent for the offering.

The Crone Law Group, PC is acting as legal counsel to Inspire Veterinary Partners, Inc. and Sichenzia Ross Ference Carmel LLP is acting as legal counsel to D. Boral Capital for the offering.

The common stock (or pre-funded warrants in lieu thereof), warrants and the shares of common stock underlying the warrants described above are being offered by the Company pursuant to a "shelf" registration statement on Form S-3 (File No. 333-282355) that was declared effective by the Securities and Exchange Commission (the "SEC") on October 11, 2024. The offering of the shares of common stock (or pre-funded warrants in lieu thereof), warrants and the shares of common stock underlying the warrants in the registered direct offering is being made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. A final prospectus supplement and accompanying prospectus relating to the registered direct offering will be filed with the SEC. Electronic copies of the final prospectus supplement and accompanying prospectus may be obtained, when available, on the SEC's website at http://www.sec.gov and may also be obtained, when available, by contacting D. Boral Capital at 590 Madison Ave 39th Floor, New York, New York 10022, by phone at (212) 970-5150 or e-mail at [email protected].

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Inspire Veterinary Partners, Inc.

Inspire Veterinary Partners is an owner/operator of veterinary hospitals in the US. As the Company expands, it expects to acquire additional veterinary hospitals, including general practice, mixed animal facilities, and critical and emergency care.

For more information, please visit: www.inspirevet.com.

Connect with Inspire Veterinary Partners, Inc.

Facebook
https://www.facebook.com/InspireVeterinaryPartners/

LinkedIn
https://www.linkedin.com/company/inspire-veterinary-partners/

Forward-Looking Statements

This press release contains forward-looking statements regarding the Company's current expectations. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, statements by the Company relating to the completion of the offering, the satisfaction of customary closing conditions related to the offering, the exercise of the warrants prior to their expiration dates, the intended use of proceeds from the offering, receipt of Stockholder Approval as well as risks and uncertainties related to the satisfaction of customary closing conditions related to anticipated acquisitions, or factors that result in changes to the Company's anticipated results of operations related to acquisitions. These and other risks and uncertainties are described more fully in the section captioned "Risk Factors" in the Company's public filings made with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law.

Investor Contact
TraDigital IR
Kevin McGrath
+1-646-418-7002
[email protected]

General Inquires
Morgan Wood
[email protected]

SOURCE: INSPIRE VETERINARY PARTNERS, INC.



View the original press release on ACCESS Newswire

D.Ford--TFWP